Cargando…

Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort Study

INTRODUCTION: Limited data are available on the long-term impact of mild renal dysfunction (estimated glomerular filtration rate [eGFR] 60–89 mL/min/1.73 m(2)) in patients with three-vessel coronary disease (3VD). METHODS: A total of 5,272 patients with 3VD undergoing revascularization were included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Guyu, Yuan, Deshan, Wang, Peizhi, Li, Tianyu, Jiang, Lin, Xu, Lianjun, Tian, Jian, Zhao, Xueyan, Feng, Xinxing, Wang, Dong, Zhang, Yin, Sun, Kai, Xu, Jingjing, Liu, Ru, Xu, Bo, Zhao, Wei, Hui, Rutai, Gao, Runlin, Song, Lei, Yuan, Jinqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664319/ https://www.ncbi.nlm.nih.gov/pubmed/37827147 http://dx.doi.org/10.1159/000534252

Ejemplares similares

Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease
por: Li, Tianyu, et al.
Publicado: (2022)

Susceptible gene polymorphism in patients with three-vessel coronary artery disease
por: Liu, Ru, et al.
Publicado: (2020)

Prediabetes and long‐term outcomes in patients with three‐vessel coronary artery disease: A large single‐center cohort study
por: Yuan, Deshan, et al.
Publicado: (2020)

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort
por: Wang, Peizhi, et al.
Publicado: (2022)

Real-world long-term outcomes based on three therapeutic strategies in very old patients with three-vessel disease
por: Yuan, Deshan, et al.
Publicado: (2021)

Association between inflammation, body mass index, and long-term outcomes in patients after percutaneous coronary intervention: A large cohort study
por: Zeng, Guyu, et al.
Publicado: (2023)

Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China
por: Zhao, Xueyan, et al.
Publicado: (2021)

HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins
por: Li, Jiawen, et al.
Publicado: (2023)

Association of prognostic nutritional index level and diabetes status with the prognosis of coronary artery disease: a cohort study
por: Li, Tianyu, et al.
Publicado: (2023)

Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease
por: Zhao, Xueyan, et al.
Publicado: (2021)

Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort Study
por: Zhang, Ce, et al.
Publicado: (2019)

5-Year Clinical Outcomes of Successful Recanalisation for Coronary Chronic Total Occlusions in Patients With or Without Type 2 Diabetes Mellitus
por: Wang, Peizhi, et al.
Publicado: (2021)

Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study
por: Li, Tianyu, et al.
Publicado: (2022)

Association between cumulative lipoprotein(a) exposure and adverse cardiovascular outcomes in patients with prediabetes or diabetes
por: Wang, Peizhi, et al.
Publicado: (2023)

Long-Term Clinical Outcomes for Non-ST Elevation Acute Coronary Syndrome Patients with High-Risk Angiographic Findings Undergoing Percutaneous Coronary Intervention
por: Jia, Sida, et al.
Publicado: (2020)

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
por: Yuan, Deshan, et al.
Publicado: (2021)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
por: Li, Jiawen, et al.
Publicado: (2021)

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention
por: Liu, Ru, et al.
Publicado: (2022)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Tianyu, et al.
Publicado: (2021)

Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
por: Yan, Kailun, et al.
Publicado: (2023)

Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study
por: Yuan, Deshan, et al.
Publicado: (2021)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study
por: Liu, Ru, et al.
Publicado: (2023)

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2020)

A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2023)

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
por: Li, Yulong, et al.
Publicado: (2022)

Five-year outcomes of biodegradable versus second-generation durable polymer drug-eluting stents used in complex percutaneous coronary intervention
por: Xu, Na, et al.
Publicado: (2023)

Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients
por: Li, Tianyu, et al.
Publicado: (2023)

Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center Data
por: Liu, Ru, et al.
Publicado: (2019)

Prognostic significance of inflammation in patients with coronary artery disease at low residual inflammatory risk
por: Li, Tianyu, et al.
Publicado: (2023)

Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention
por: Zhao, Xueyan, et al.
Publicado: (2019)

Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China
por: Li, Jiawen, et al.
Publicado: (2023)

Novel Platelet Function Analyzer 200 Predicts Blood Transfusion After Elective Cardiac Surgery in Patients Suspended on Dual Antiplatelet Therapy
por: Cui, Wen, et al.
Publicado: (2023)

Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study
por: Xu, Na, et al.
Publicado: (2022)

Stress hyperglycemia ratio and long‐term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study
por: Zeng, Guyu, et al.
Publicado: (2023)

Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
por: Tang, Xiaofang, et al.
Publicado: (2021)

Prevalence and Prognostic Significance of Malnutrition in Patients with Abnormal Glycemic Status and Coronary Artery Disease: A Multicenter Cohort Study in China
por: Li, Tianyu, et al.
Publicado: (2023)

Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus
por: Teng, Zhenjie, et al.
Publicado: (2022)

The Effect of Cerebral Small Vessel Disease on the Subtypes of Mild Cognitive Impairment
por: Li, Xudong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_laoun00cldpr6ndm2njkbf9m6e